Evidence map›Paper›PMID 32662861›Full record

SynthesisJAMA2020

Association of Radial Artery Graft vs Saphenous Vein Graft With Long-term Cardiovascular Outcomes Among Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis.

Mario Gaudino, Umberto Benedetto, Stephen Fremes, Karla Ballman, Giuseppe Biondi-Zoccai, Art Sedrakyan, Giuseppe Nasso, Jai Raman, Brian Buxton, Philip A Hayward and 15 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in JAMA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Soft robotic devices for cardiovascular medicine.Nature reviews. Cardiology · 2026
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Direct in vivo reprogramming to relieve tissue ischemia via induced vasculogenesis.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Mario GaudinoDepartment of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.
Umberto BenedettoDepartment of Cardiac Surgery, Bristol Heart Institute, Bristol, United Kingdom.
Stephen FremesDepartment of Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Karla BallmanDepartment of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
Giuseppe Biondi-ZoccaiDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University, Rome, Italy.
Art SedrakyanDepartment of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
Giuseppe NassoCardiothoracic and Vascular Department, Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Italy.
Jai RamanAustin Hospital, Melbourne, Victoria, Australia.
Brian BuxtonDepartment of Surgery, University of Melbourne, Melbourne, Victoria, Australia.
Philip A HaywardDepartment of Surgery, University of Melbourne, Melbourne, Victoria, Australia.
Neil MoatNHLI, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Peter CollinsNHLI, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Carolyn WebbNHLI, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Miodrag PericDedinje Cardiovascular Institute and Belgrade University School of Medicine, Belgrade, Serbia.
Ivana PetrovicDedinje Cardiovascular Institute and Belgrade University School of Medicine, Belgrade, Serbia.
Kyung J YooYonsei University College of Medicine, Seoul, South Korea.
Irbaz HameedDepartment of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.
Antonino Di FrancoDepartment of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.
Marco MoscarelliCardiothoracic and Vascular Department, Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Italy.
Giuseppe SpezialeCardiothoracic and Vascular Department, Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Italy.
John D PuskasDepartment of Cardiovascular Surgery, Mount Sinai St. Luke's, New York, New York.
Leonard N GirardiDepartment of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.
David L HareFaculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
David P TaggartNuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
RADIAL Investigators

Funding

Randomized comparison of the clinical Outcome of single versus Multiple Arterial grafts: Quality of Life (ROMA:QOL)R01HL152021 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI GAUDINO, MARIO FL, MASTERSON CREBER, RUTH MARIE · 2020 to 2024
$4.1M
NHLBI NIH HHS R01 HL152021
6 · The paper itself

Abstract

Importance: Observational studies have suggested that the use of radial artery grafts for coronary artery bypass grafting may improve clinical outcomes compared with the use of saphenous vein grafts, but this has not been confirmed in randomized trials. Objective: To compare clinical outcomes between patients receiving radial artery vs saphenous vein grafts for coronary artery bypass grafting after long-term follow-up. Design, Setting, and Participants: Patient-level pooled analysis comparing radial artery vs saphenous vein graft in adult patients undergoing isolated coronary artery bypass grafting from 5 countries (Australia, Italy, Serbia, South Korea, and the United Kingdom), with enrollment from 1997 to 2009 and follow-up completed in 2019. Interventions: Patients were randomized to undergo either radial artery (n = 534) or saphenous vein (n = 502) grafts for coronary artery bypass grafting. Main Outcomes and Measures: The primary outcome was a composite of death, myocardial infarction, or repeat revascularization and the secondary outcome was a composite of death or myocardial infarction. Results: A total of 1036 patients were randomized (mean age, 66.6 years in the radial artery group vs 67.1 years in the saphenous vein group; 376 [70.4%] men in the radial artery group vs 351 [69.9%] in the saphenous vein group); 942 (90.9%) of the originally randomized patients completed 10 years of follow-up (510 in the radial artery group). At a median (interquartile range) follow-up of 10 (10-11) years, the use of the radial artery, compared with the saphenous vein, in coronary artery bypass grafting was associated with a statistically significant reduction in the incidence of the composite outcome of death, myocardial infarction, or repeat revascularization (220 vs 237 total events; 41 vs 47 events per 1000 patient-years; hazard ratio, 0.73 [95% CI, 0.61-0.88]; P < .001) and of the composite of death or myocardial infarction (188 vs 193 total events; 35 vs 38 events per 1000 patient-years; hazard ratio, 0.77 [95% CI, 0.63-0.94]; P = .01). Conclusions and Relevance: In this individual participant data meta-analysis with a median follow-up of 10 years, among patients undergoing coronary artery bypass grafting, the use of the radial artery compared with the saphenous vein was associated with a lower risk of a composite of cardiovascular outcomes.

Indexed as

AgedCoronary Artery BypassFemaleFollow-Up StudiesHumansIncidenceMaleMyocardial InfarctionPostoperative ComplicationsRadial ArteryRandomized Controlled Trials as TopicReoperationSaphenous VeinTime FactorsTreatment Outcome

Identifiers

PMID32662861
PMCPMC7361649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.